Regulated cell death (RCD) in cancer: key pathways and targeted therapies
F Peng, M Liao, R Qin, S Zhu, C Peng, L Fu… - Signal transduction and …, 2022 - nature.com
Regulated cell death (RCD), also well-known as programmed cell death (PCD), refers to the
form of cell death that can be regulated by a variety of biomacromolecules, which is …
form of cell death that can be regulated by a variety of biomacromolecules, which is …
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein
tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis …
tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis …
Triple negative breast cancer treatment options and limitations: future outlook
O Obidiro, G Battogtokh, EO Akala - Pharmaceutics, 2023 - mdpi.com
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …
M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …
Discovery of a highly potent and selective dual PROTAC degrader of CDK12 and CDK13
Selective degradation of the cyclin-dependent kinases 12 and 13 (CDK12/13) presents a
novel therapeutic opportunity for triple-negative breast cancer (TNBC), but there is still a lack …
novel therapeutic opportunity for triple-negative breast cancer (TNBC), but there is still a lack …
Structure-guided design of a small-molecule activator of sirtuin-3 that modulates autophagy in triple negative breast cancer
J Zhang, L Zou, D Shi, J Liu, J Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Sirtuin-3 (SIRT3) is an NAD+-dependent protein deacetylase localized primarily in the
mitochondria with many links to different types of human cancers. Autophagy, which is a …
mitochondria with many links to different types of human cancers. Autophagy, which is a …
Discovery of novel fedratinib-based HDAC/JAK/BRD4 triple inhibitors with remarkable antitumor activity against triple negative breast cancer
C Zhao, Y Zhang, J Zhang, S Li, M Liu… - Journal of Medicinal …, 2023 - ACS Publications
Multitarget HDAC inhibitors capable of simultaneously blocking the BRD4-LIFR-JAK1-
STAT3 signaling pathway hold great potential for the treatment of TNBC and other solid …
STAT3 signaling pathway hold great potential for the treatment of TNBC and other solid …
Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer
Y Zhen, Z Yuan, J Zhang, Y Chen, Y Fu, Y Liu… - Cell death & …, 2022 - nature.com
Breast cancer is still one of the most common malignancies worldwide and remains a major
clinical challenge. We previously reported that the anthelmintic drug flubendazole induced …
clinical challenge. We previously reported that the anthelmintic drug flubendazole induced …
Discovery of potent and selective CDK9 degraders for targeting transcription regulation in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is highly aggressive with very limited treatment
options due to the lack of efficient targeted therapies and thus still remains clinically …
options due to the lack of efficient targeted therapies and thus still remains clinically …
Targeting of the FOXM1 oncoprotein by E3 ligase-assisted degradation
G Luo, X Lin, A Vega-Medina, M Xiao, G Li… - Journal of Medicinal …, 2021 - ACS Publications
The transcription factor FOXM1 that regulates multiple proliferation-related genes through
selective protein-DNA and protein–protein interactions is now considered an attractive …
selective protein-DNA and protein–protein interactions is now considered an attractive …